Oppenheimer & Co’s SEQUENOM INC NEW SQNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-75,096
Closed -$131K 1428
2015
Q3
$131K Sell
75,096
-280,710
-79% -$687K ﹤0.01% 1238
2015
Q2
$1.08M Buy
355,806
+339,769
+2,119% +$1.28M 0.03% 601
2015
Q1
$63K Sell
16,037
-11,784
-42% -$43.3K ﹤0.01% 1442
2014
Q4
$103K Sell
27,821
-8
-0% -$26 ﹤0.01% 1326
2014
Q3
$83K Sell
27,829
-66,863
-71% -$245K ﹤0.01% 1358
2014
Q2
$366K Buy
94,692
+29,310
+45% +$85.7K 0.01% 979
2014
Q1
$160K Buy
65,382
+4,500
+7% +$10.7K ﹤0.01% 1279
2013
Q4
$142K Sell
60,882
-18,692
-23% -$44.3K ﹤0.01% 1266
2013
Q3
$212K Sell
79,574
-4,845
-6% -$16.3K 0.01% 1135
2013
Q2
$355K Buy
+84,419
New +$338K 0.01% 854

Other funds holding SQNM

Oppenheimer & Co's SQNM Position: Q4 2015 in Review

Oppenheimer & Co sold out of SEQUENOM INC NEW (SQNM) in Q4 2015, closing a stake of 75,096 shares — an estimated $131K sold.

Oppenheimer & Co first reported a position in SQNM in Q2 2013 and held it in 10 quarters. The position peaked at $1.08M in Q2 2015. 108 funds tracked by Wall St. Rank hold SQNM as of Q4 2015.

  • Oppenheimer & Co reported no remaining SEQUENOM INC NEW position as of Q4 2015 after selling out during the quarter.
  • Oppenheimer & Co sold 75,096 SEQUENOM INC NEW shares in Q4 2015, an estimated $131K.
  • Oppenheimer & Co first reported a position in SEQUENOM INC NEW in Q2 2013 and held it in 10 quarters.
  • Oppenheimer & Co's SEQUENOM INC NEW position peaked at $1.08M in Q2 2015.
  • 108 funds tracked by Wall St. Rank held SEQUENOM INC NEW as of Q4 2015.

Based on Oppenheimer & Co's 13F filing for Q4 2015, filed 3 Feb 2016.